Clinical Trials Update: March 4, 2008
Vaccines
Arrhythmia
Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)
|
E-mail this article
Subscribe to news
Printer friendly version
|
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Vaccines
This is a 5 1/2 year study involving nine office visits. Candidates must not have had a flu or pneumonia shot this season, and cannot be allergic to eggs.
The research site is in Clearwater, Fla.
More information
Please see http://www.centerwatch.com/patient/studies/cat372.html 
.
-----
Arrhythmia
This study will evaluate the safety and effectiveness of a new ablation catheter that uses light energy versus the standard drug therapy for atrial fibrillation. You may qualify if you are aged 18 to 65, and have failed to respond to drug treatment for atrial fibrillation or find the side effects of the medication intolerable.
The research site is in Houston, Texas.
More information
Please see http://www.centerwatch.com/patient/studies/cat515.html .
-----
Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)
Children aged 6 to 17 diagnosed with ADHD may be eligible to participate in this study. Compensation may be available for time and travel, and study related examinations and care will be provided at no cost.
The research site is in Cypress, Calif.
More information
Please see http://www.centerwatch.com/patient/studies/cat18.html .
-----
Copyright 2008 Thomson CenterWatch . All rights reserved.
Copyright © 2008 ScoutNews, LLC. All rights reserved. 
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder.gov does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder.gov health library.